Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Purcell

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
American Journal of Physiology. Heart and Circulatory Physiology|July 7, 2018
Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodelingBrendan P Purcell, Shayne C Barlow, Paige E Perreault, et al.
Circulation|September 14, 2013
Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarctionJohn W MacArthur, Brendan P Purcell, Yasuhiro Shudo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2018
Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast CancerElspeth Ward, Damir Varešlija, Sara Charmsaz, et al.
Journal of Cardiovascular Development and Disease|November 20, 2020
A Bioengineered Neuregulin-Hydrogel Therapy Reduces Scar Size and Enhances Post-Infarct Ventricular Contractility in an Ovine Large Animal ModelJeffrey E Cohen, Andrew B Goldstone, Hanjay Wang, et al.
Nature Materials|April 1, 2014
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibitionBrendan P Purcell, David Lobb, Manoj B Charati, et al.
Circulation. Heart Failure|June 7, 2014
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathyJeffrey E Cohen, Brendan P Purcell, John W MacArthur, et al.
Science Translational Medicine|February 14, 2014
Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarctionShaina R Eckhouse, Brendan P Purcell, Jeremy R McGarvey, et al.
BMJ (Clinical Research Ed.)|January 27, 2007
Open letter to the leader of academic medicineJohn P A Ioannidis, Tahmeed Ahmed, Shally Awasthi, et al.
Oncogene|January 9, 2021
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotypeDamir Varešlija, Elspeth Ward, Siobhan P Purcell, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
American Journal of Physiology. Heart and Circulatory Physiology|July 7, 2018
Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodelingBrendan P Purcell, Shayne C Barlow, Paige E Perreault, et al.
Circulation|September 14, 2013
Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarctionJohn W MacArthur, Brendan P Purcell, Yasuhiro Shudo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2018
Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast CancerElspeth Ward, Damir Varešlija, Sara Charmsaz, et al.
Journal of Cardiovascular Development and Disease|November 20, 2020
A Bioengineered Neuregulin-Hydrogel Therapy Reduces Scar Size and Enhances Post-Infarct Ventricular Contractility in an Ovine Large Animal ModelJeffrey E Cohen, Andrew B Goldstone, Hanjay Wang, et al.
Nature Materials|April 1, 2014
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibitionBrendan P Purcell, David Lobb, Manoj B Charati, et al.
Circulation. Heart Failure|June 7, 2014
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathyJeffrey E Cohen, Brendan P Purcell, John W MacArthur, et al.
Science Translational Medicine|February 14, 2014
Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarctionShaina R Eckhouse, Brendan P Purcell, Jeremy R McGarvey, et al.
BMJ (Clinical Research Ed.)|January 27, 2007
Open letter to the leader of academic medicineJohn P A Ioannidis, Tahmeed Ahmed, Shally Awasthi, et al.
Oncogene|January 9, 2021
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotypeDamir Varešlija, Elspeth Ward, Siobhan P Purcell, et al.
Pageof 8